Implantable insulin pumps

Lancet

Volumn 354, Issue 9174, 1999, Pages 178-179

  Selam, J L ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TITANIUM;

DRUG SAFETY; DRUG SELF ADMINISTRATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPLANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INTESTINE ABSORPTION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NEBULIZER; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS SECRETION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

EID: 0033578274     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90034-X     Document Type: Note

References (13)

1. Blackshear P.J., Dorman F.D., Blackshear P.L. Jr., Varco R.L., Buchwald H. A permanently implantable self-recycling low flow constant rate multipurpose infusion pump of simple design. Surg Forum. 21:1970;136.
2. Albisser A.M., Leibel B.S., Ewart T.G.et al. Clinical control of diabetes by the artificial pancreas. Diabetes. 23:1974;397-404.
3. Blackshear P.J., Rohde T.D., Grotting J.C.et al. Control of blood glucose in experimental diabetes by means of a totally implantable insulin infusion device. Diabetes. 28:1979;634-639.
4. Selam J.L., Medlej R., M'Bemba J.et al. Symptoms, hormones, and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in type 1 diabetes. Diabet Med. 12:1995;1102-1109.
5. Haardt M.J., Selam J.L., Slama G.et al. A cost-benefit comparison of intensive diabetes managements with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes. Diabetes Care. 17:1994;847-851.
6. Saudek C.D., Duckworth W.C., Giobbie-Hurder A.et al. Implantable insulin pumps vs multiple-dose insulin for non-insulin-dependent diabetes mellitus. JAMA. 276:1996;1322-1327.
7. Abraira C., Colwell J.A., Nuttall F.Q.et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Diabetes Care. 18:1995;1112-1123.
8. Duckworth W.C., Saudek C.D., Giobbie-Hurder A.et al. The Veterans Affairs Implantable Insulin Pump Study. Effect on cardiovasclar risk factors. Diabetes Care. 21:1998;1596-1602.
9. Duckworth W.C., Saudek C.D., Henry R.R. Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes. 41:1992;657-661.
10. Broussolle C., Jeandidier N., Hanair-Broutin H. French multicentre experience of implantable insulin pumps. Lancet. 343:1994;514-515.
11. Lassmann-Vague V., Guerci B., Hanaire-Broutin H.et al. Use of implantable insulin pumps: the EVADIAC position. Diabetes Metab. 23:1997;234-250.
12. Hanaire-Broutin H., Broussolle C., Jeandidier N.et al. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. Diabetes Care. 18:1995;388-392.
13. Laube B.L., Benedict G.W., Dobs A.S. The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. Chest. 114:1998;1734-1739.